SCHEMBL19784429

SCHEMBL19784429

CC(C)(C)OC(=O)N(CCc1ccc(O)c2[nH]c(=O)ccc12)Cc1ccc(C(=O)O)cc1F

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 15/20 0.39
ADRB1 P08588 8/20 0.39
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
HDAC1 Q13547 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC2 Q92769 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
EPHX2 P34913 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
LTA4H P09960 1/20 0.34
ADRB3 P13945 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19784017 0.91 ADRB2 (0.40) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL19784019 0.90 ADRB2 (0.38) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL19784022 0.90 ADRB2 (0.39) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL24404494 0.89 ADRB2 (0.43) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL24404535 0.88 ADRB2 (0.37) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL19784007 0.88 HDAC1 (0.42) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL24404433 0.87 ADRB2 (0.40) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL22839839 0.87 ADRB2 (0.40) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL19784427 0.86 HDAC1 (0.46) ADRB2ADRB1DRD2DRD1DRD4
SCHEMBL19784428 0.85 ADRB2 (0.39) ADRB2ADRB1DRD2DRD1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3256464-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2022-05-11 EP disclosed
WO-2018011090-A1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2018-01-18 WO disclosed